The History of Photodetection and Photodynamic Therapy¶

Abstract Light has been employed in the treatment of disease since antiquity. Many ancient civilizations utilized phototherapy, but it was not until early last century that this form of therapy reappeared. Following the scientific discoveries by early pioneers such as Finsen, Raab and Von Tappeiner, the combination of light and drug administration led to the emergence of photochemotherapy as a therapeutic tool. The isolation of porphyrins and the subsequent discovery of their tumor-localizing properties and phototoxic effects on tumor tissue led to the development of modern photodetection (PD) and photodynamic therapy (PDT). This review traces the origins and development of PD and PDT from antiquity to the present day.

[1]  U. Pichlmeier,et al.  No Generalized Skin Phototoxicity after Intravesical Application of 5-Aminolevulinic Acid for Fluorescence Diagnosis ofSuperficial Bladder Cancer , 2000, Urologia Internationalis.

[2]  O J Balchum,et al.  Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphvrin derivative , 1984, Lasers in surgery and medicine.

[3]  H Kerl,et al.  Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. , 1997, Journal of photochemistry and photobiology. B, Biology.

[4]  D. Vernon,et al.  Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. , 1993, Journal of photochemistry and photobiology. B, Biology.

[5]  H Stepp,et al.  Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[6]  Herbert Stepp,et al.  Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy , 1999, European Urology.

[7]  T. Dougherty,et al.  Studies on the mechanism of tumor destruction by photoradiation therapy. , 1984, Progress in clinical and biological research.

[8]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[9]  K. Schomacker,et al.  Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid , 1999, BJU international.

[10]  D. Kessel,et al.  Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients. , 1997, Journal of photochemistry and photobiology. B, Biology.

[11]  B. Overholt,et al.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.

[12]  U. Nseyo,et al.  Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. , 1998, The Journal of urology.

[13]  M. Berns,et al.  Laser photoradiation therapy of cancer: An update of the experience at the university of California, Irvine , 1984, Lasers in surgery and medicine.

[14]  J. Spikes The Historical Development of Ideas on Applications of Photosensitized Reactions in the Health Sciences , 1985 .

[15]  M. Gray,et al.  Hematoporphyrin derivative for detection and management of cancer , 1967, Cancer.

[16]  W. Cheong,et al.  Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy. , 2000, Circulation.

[17]  J R Leonard,et al.  Hematoporphyrin fluorescence: An aid in diagnosis of malignant neoplasms , 1971, The Laryngoscope.

[18]  Manganiello Lo,et al.  Studies on cancer detection and therapy; the affinity of neoplastic, embryonic, and traumatized tissue for porphyrins, metalloporphyrins, and radioactive zinc hematoporphyrin. , 1948 .

[19]  T. Fitzpatrick,et al.  Historical aspects of methoxsalen and other furocoumarins. , 1959, The Journal of investigative dermatology.

[20]  V. Fingar,et al.  Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[21]  Daniel R. Doiron,et al.  SnET2: clinical update , 1996, Photonics West.

[22]  H. Kato,et al.  Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.

[23]  T. Dougherty,et al.  Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. , 1998, The Annals of thoracic surgery.

[24]  M. Berns,et al.  Laser photoradiation therapy of cancer following hematoporphyrin sensitization , 1982, Lasers in surgery and medicine.

[25]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[26]  M. Korbelik,et al.  Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. , 1999, Cancer letters.

[27]  T. Dougherty HEMATOPORPHYRIN AS A PHOTOSENSITIZER OF TUMORS * , 1983, Photochemistry and photobiology.

[28]  H. Messmann 5-Aminolevulinic acid-induced protoporphyrin IX for the detection of gastrointestinal dysplasia. , 2000, Gastrointestinal endoscopy clinics of North America.

[29]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[30]  D. Ost Photodynamic therapy in lung cancer. A review. , 2003, Methods in molecular medicine.

[31]  Richard L. Lipson,et al.  Transactions of the Ninetieth Annual Meeting of the American Gynecological Society—continuedUse of hematoporphyrin derivative in detection and management of cervical cancer: A preliminary report☆☆☆ , 1967 .

[32]  E J BALDES,et al.  The photodynamic properties of a particular hematoporphyrin derivative. , 1960, Archives of dermatology.

[33]  T. Fitzpatrick,et al.  Part IV: Basic Considerations of the Psoralens: Historical Aspects of Methoxsalen and Other Furocoumarins1 , 1959 .

[34]  F. Figge,et al.  Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[36]  R Baumgartner,et al.  Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.

[37]  J P Cooke,et al.  Photoangioplasty for Human Peripheral Atherosclerosis: Results of a Phase I Trial of Photodynamic Therapy With Motexafin Lutetium (Antrin) , 2000, Circulation.

[38]  A. Moor,et al.  Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.

[39]  A E Profio,et al.  Laser fluorescence bronchoscope for localization of occult lung tumors. , 1979, Medical physics.

[40]  D. Kessel,et al.  Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.

[41]  D. Drabkin INTRODUCTION: SOME HISTORICAL HIGHLIGHTS IN KNOWLEDGE OF PORPHYRINS AND PORPHYRIAS , 1963 .

[42]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[43]  J. Potter,et al.  Can Breast Carcinoma be Anticipated?: A Follow‐up of Benign Breast Biopsies , 1968, Annals of surgery.

[44]  E J BALDES,et al.  Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. , 1961, The Journal of thoracic and cardiovascular surgery.

[45]  E J BALDES,et al.  The use of a derivative of hematoporhyrin in tumor detection. , 1961, Journal of the National Cancer Institute.

[46]  B. Jarvis,et al.  Topical Aminolevulinic Acid HCl Photodynamic Therapy , 2000, American journal of clinical dermatology.

[47]  M. C. Berenbaum,et al.  Photodynamic destruction of human bladder carcinoma. , 1975, British Journal of Cancer.

[48]  M C Berenbaum,et al.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. , 1986, British Journal of Cancer.

[49]  J Moan,et al.  On the pharmacokinetics of topically applied 5‐aminolevulinic acid and two of its esters , 2001, International journal of cancer.

[50]  F. Figge,et al.  Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin , 1955, Surgical forum.

[51]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[52]  Christian Gluud,et al.  Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.

[53]  B. Ward,et al.  The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment. , 1982, American journal of obstetrics and gynecology.

[54]  V. Schweitzer Photodynamic therapy for treatment of head and neck cancer , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[55]  M. Metzdorff,et al.  Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. , 1990, Chest.

[56]  S. Granick HEPATIC PORPHYRIA AND DRUG‐INDUCED OR CHEMICAL PORPHYRIA * , 1965, Annals of the New York Academy of Sciences.

[57]  Joris Kloek,et al.  Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.

[58]  J C Kennedy,et al.  Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.

[59]  T. Dougherty,et al.  Lasers and hematoporphyrin derivative in cancer , 1983 .

[60]  B. Overholt,et al.  Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. , 1995, Gastrointestinal endoscopy.

[61]  H. C. Robertson,et al.  Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.

[62]  D. Doiron,et al.  Dose measurements in photodynamic therapy of cancer , 1987, Lasers in surgery and medicine.

[63]  B. Wilson,et al.  Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. , 1996, Journal of clinical laser medicine & surgery.

[64]  W. Morison Phototherapy and photochemotherapy. , 1992, Advances in dermatology.

[65]  C. Wilson,et al.  Photodynamic therapy of malignant tumours. , 1972, Lancet.

[66]  R Baumgartner,et al.  Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.

[67]  N. Müller,et al.  Predicting the response of obstructive endobronchial tumors to photodynamic therapy , 1986, Cancer.

[68]  H. Kato,et al.  Fiberoptic bronchoscopic laser photoradiation for tumor localization in lung cancer. , 1982, Chest.

[69]  S. Bown,et al.  The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. , 1991, The Journal of urology.

[70]  D. Fraker,et al.  Preliminary Report of Photodynamic Therapy for Intraperitoneal Sarcomatosis , 2001, Annals of Surgical Oncology.

[71]  M. Snell,et al.  Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.

[72]  T. Wieman,et al.  Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[73]  F. Figge,et al.  Cancer detection and therapy. II. Methods of preparation and biological effects of metallo-porphyrins. , 1951, Bulletin of the School of Medicine.

[74]  F. Figge,et al.  Use of hematoporphyrin fluorescence in biliary and cancer surgery. , 1955, The American surgeon.

[75]  Alan R. Morgan,et al.  The Diels-Alder reactions of protoporphyrin IX dimethyl ester with electron-deficient alkynes , 1986 .

[76]  K. Berg,et al.  THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.

[77]  E. Reddi,et al.  Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin. , 1984, Progress in clinical and biological research.

[78]  J. Hill,et al.  A history of photodynamic therapy. , 1991, The Australian and New Zealand journal of surgery.

[79]  M. Biel Photodynamic therapy and the treatment of head and neck neoplasia , 1998, The Laryngoscope.

[80]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[81]  A. M. Olsen,et al.  The use of a derivative of hematoporphyrin in tumor detection. , 1961 .

[82]  G. Stables,et al.  Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.

[83]  Jos. Seherer Chemisch‐physiologische Untersuchungen , 1841 .

[84]  T J Dougherty,et al.  The structure of the active component of hematoporphyrin derivative. , 1984, Progress in clinical and biological research.

[85]  J. H. Kinsey,et al.  Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. , 1983, The Journal of urology.

[86]  A. Berner,et al.  Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.

[87]  M. Kaplan,et al.  Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2) , 1998, Journal of surgical oncology.

[88]  Chi-Wei Lin,et al.  Photodynamic Therapy With Hematoporphyrin Derivative in the Treatment of Superficial Transitional-Cell Carcinoma of the Bladder , 1988 .

[89]  B. Wilson,et al.  Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.

[90]  James S. McCaughan,et al.  Palliation of esophageal malignancy with photoradiation therapy , 1984, Cancer.

[91]  T. Okunaka,et al.  A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  J. Sessler,et al.  Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy. , 2000, Biochemical pharmacology.

[93]  H Stepp,et al.  Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. , 2001, The Journal of urology.

[94]  J. H. Kinsey,et al.  Detection of hematoporphyrin fluorescence during fiberoptic bronchoscopy to localize early bronchogenic carcinoma. , 1978, Mayo Clinic proceedings.

[95]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[96]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. , 1998, Gastroenterology.

[97]  E. Farrero,et al.  Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction. , 1999, The European respiratory journal.

[98]  J. H. Kinsey,et al.  Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. , 1979, Mayo Clinic proceedings.

[99]  P. Okunieff,et al.  Phase I trial of photo dynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder , 1997 .

[100]  C. Gomer,et al.  Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors: examination of acute normal ocular tissue toxicity. , 1983, Cancer research.

[101]  T. Weingeist,et al.  Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. , 1984, Archives of ophthalmology.

[102]  G. Elder Haem Synthesis and the Porphyrias , 1994 .

[103]  J. Feyh Photodynamic treatment for cancers of the head and neck. , 1996, Journal of photochemistry and photobiology. B, Biology.

[104]  H. Kato,et al.  Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract. , 1985, Seminars in surgical oncology.

[105]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[106]  R. Anderson,et al.  Topical ALA-photodynamic therapy for the treatment of acne vulgaris. , 2000, The Journal of investigative dermatology.

[107]  I. Stender,et al.  Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.

[108]  T. Sutedja,et al.  Photodynamic therapy in lung cancer. A review. , 1996, Journal of photochemistry and photobiology. B, Biology.

[109]  M F Mafee,et al.  Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.

[110]  S. Lam Photodynamic therapy of lung cancer. , 1993, Thorax.

[111]  D. Phillips,et al.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.

[112]  Q. Peng,et al.  Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. , 1996, Ultrastructural pathology.

[113]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .

[114]  C. Whitehurst,et al.  Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.

[115]  M L Agarwal,et al.  Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. , 1991, Cancer research.

[116]  T J Dougherty,et al.  PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.

[117]  P. Okunieff,et al.  Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. , 1997, Urology.

[118]  A H Kaye,et al.  Selective uptake of hematoporphyrin derivative into human cerebral glioma. , 1990, Neurosurgery.

[119]  A. Jaakkola,et al.  [Photodynamic therapy of age-related macular degeneration]. , 2002, Duodecim; laaketieteellinen aikakauskirja.

[120]  N. J. Brown,et al.  MATERIALS AND METHODS Cell lines Human umbilical vein endothelial cells , 2022 .

[121]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[122]  W. Star,et al.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.

[123]  P. D. Smith,et al.  Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. , 1986, British Journal of Cancer.

[124]  K. Ghiggino,et al.  EFFECTS OF TRYPTOPHAN OXIDATION ON BACTERIORHODOPSIN STRUCTURE AND FUNCTION , 1984 .

[125]  D. Kessel,et al.  CHEMISTRY OF HEMATOPORPHYRIN‐DERIVED PHOTOSENSITIZERS , 1987, Photochemistry and photobiology.

[126]  D. Ladner,et al.  Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid , 2001, British Journal of Cancer.

[127]  Thomas J. Dougherty,et al.  Basic principles of photodynamic therapy , 2001 .

[128]  J. Sessler,et al.  Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble Photosensitizer , 1996, Photochemistry and photobiology.

[129]  R. Lipson,et al.  Hematoporphyrin-derivative-fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia, and carcinoma in situ of the cervix uteri. , 1973, American journal of obstetrics and gynecology.

[130]  D. Ash,et al.  Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.

[131]  H. Barr,et al.  Photodynamic therapy for colorectal cancer: A quantitative pilot study , 1990, The British journal of surgery.

[132]  M J Gray,et al.  Use of hematoporphyrin derivative in detection and management of cervical cancer. , 1967, American journal of obstetrics and gynecology.

[133]  A. J. MacRobert,et al.  Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. , 1998, British Journal of Cancer.

[134]  D. Phillips,et al.  EHPnet: Doing a World of Good , 1998, Environmental Health Perspectives.

[135]  M T Tseng,et al.  A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. , 1989, Radiation research.

[136]  D. Cortese,et al.  Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. , 1984, Chest.

[137]  R. Lambert,et al.  Long-term survival after photodynamic therapy for esophageal cancer. , 1995, Gastroenterology.

[138]  J C Kennedy,et al.  NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.

[139]  T J Dougherty,et al.  Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. , 1975, Journal of the National Cancer Institute.

[140]  T. Mang,et al.  A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. , 1998, The cancer journal from Scientific American.

[141]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.